About Us
Founded in 2012, Vefa İlaç operates in the research, development and production of pharmaceuticals, food supplements and dermocosmetic products.
Deep-rooted History, Forward-looking Company
With nearly half a century of experience, Vefa İlaç manufactures at national and international scale. Our modern production facility in Beylikdüzü, Istanbul, and our factory in Kırklareli bring tablet, film-coated tablet, capsule, syrup, drop, cream, and gel dosage forms together under one roof.
Our R&D center plays a pioneering role in developing high-quality formulations. Based on our number of patent and trademark registrations, we are one of the most active R&D centers in the Turkish pharmaceutical industry.
Our Mission, Vision & Strategy
Our Mission
To make a sustainable contribution to human health by developing accessible, reliable, innovative and high-quality solutions in the fields of pharmaceuticals and food supplements — through our scientific expertise, strong R&D infrastructure and advanced manufacturing technologies.
Our Vision
To become a reliable, innovative and internationally recognized Turkish health brand that — with its expertise in science, R&D and advanced manufacturing technologies — delivers the health solutions it develops to world markets through a strong export network.
Our Strategy
To create sustainable value in existing and new markets through export-oriented growth, by manufacturing the high value-added health products we develop with our R&D strength to international quality standards.
Discover Our R&D and Production Strength
Learn more about our modern facilities, broad product portfolio, and R&D infrastructure.
Our History
The Vefa İlaç Journey
Key milestones from our founding to today.
- 2012
Founded
Vefa İlaç was officially established.
- 2013
TR GMP Approval
Received TR GMP approval and started manufacturing operations.
- 2014
ISO 9001 & ISO 13485
Obtained ISO 9001 and ISO 13485 quality management certifications.
- 2016
First Generic Drug License
Received the first generic drug manufacturing license in Türkiye.
- 2018
Export GMP Certificates
Obtained export GMP certificates from countries such as Azerbaijan and Iraq.
- 2018
VEFAR-GE R&D Center
The VEFAR-GE Research & Development Center was established.
- 2018
Generic Drug Licenses Reached 29
Our number of generic drug licenses reached 29.
- 2020
Expanding Production Portfolio
Our production portfolio surpassed 115 products, with more than 6 million boxes produced.
- 2024
Growing Exports and Portfolio
40 licensed products and over 135 food-supplement SKUs were exported to 36 different countries.
- 2026
Pilot Production
Within our future vision, we aim to bring a pilot production line online.
- 2028
EU GMP Certification
European Union GMP certification, targeted as part of our future vision.